Share this article
CoreWeave Has No Plans to Boost Price in Core Scientific Takeover Battle
The company calls its offer for CORZ “best and final” as it counters hedge fund criticism and urges investors to back the deal.
Oct 17, 2025, 12:57 p.m.
What to know:
- CoreWeave says its proposed merger with Core Scientific provides the most secure path to long-term value, eliminating execution risks in CORZ's standalone plan.
- Shares of CoreWeave fell 1.5% pre-market to $140, while Core Scientific dropped 3% to $19 ahead of the October 30 vote.
CoreWeave (CRWV) announced its commitment to acquiring artificial intelligence (AI) miner Core Scientific (CORZ) under an all-stock deal that was originally agreed on July 7. In an open letter, CoreWeave called the offer “best and final,” stating that it will not be modified. The company said the merger represents the most secure and value-enhancing path forward, combining immediate premium value with significant long-term upside.
CoreWeave argued that if Core Scientific were to proceed independently, it would face substantial capital expenditure requirements and execution risks. The company urged shareholders to vote “FOR” the deal at the October 30 special meeting, emphasizing that the transaction removes major risks and offers the best chance for sustainable growth and shareholder value creation.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
The company also addressed and refuted claims from Two Seas Capital, a hedge fund opposing the deal, calling their arguments misleading and based on misinformation. CoreWeave stated that Two Seas’ assertions overlook the significant operational, financial, and execution risks Core Scientific would face on its own, while also misrepresenting the strategic value of the proposed merger. It further said that Two Seas’ narrative ignores the strong market validation reflected in Core Scientific’s stock performance and the substantial premium CoreWeave is offering.
CoreWeave shares were down 1.5% in pre-market trading at $140, while Core Scientific shares declined 3% to $19.
AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.
More For You
What to know:
- As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
- GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
- Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.
More For You
Michael Saylor's Strategy Made Second Consecutive $1B Bitcoin Purchase Last Week
Despite the continued struggles of its share price, Strategy again funded the purchase mostly via sales of common stock
What to know:
- Strategy last week purchased 10,645 bitcoin for $980.3 million.
- The fresh acquisition was mostly funded by sales of common stock.
- Total bitcoin holdings rose to 671,268 acquired for $50.33 billion, or an average price of $74,972 each.
Top Stories
